Greg Zante insider trades

Open-market stock purchases and sales by Greg Zante, Chief Financial Officer at Viking Therapeutics, Inc, from SEC Form 4 filings since Jan 4, 2021.

Recent trades

DateStockTradeValue
Jul 29, 2026VKTX Viking Therapeutics, IncSold$710K
Jul 28, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 5, 2026VKTX Viking Therapeutics, IncSold$1M
Jan 5, 2026VKTX Viking Therapeutics, IncSold$464K
Jan 5, 2026VKTX Viking Therapeutics, IncSold$48.1K
Jan 5, 2026VKTX Viking Therapeutics, IncSold$353K
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Oct 28, 2025VKTX Viking Therapeutics, IncSold$216K
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)—

Companies traded

  • VKTX Viking Therapeutics, Inc: 30 sales, last Jul 29, 2026

Get free alerts when Greg Zante files a new trade →